Bimagrumab
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
Eli Lilly · Phase 2 · Recruiting · Enrollment 63
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide + bimagrumab | Obesity or overweight | n/r | 52 | n/r | n/r |
| Tirzepatide + placebo | Obesity or overweight | n/r | 52 | n/r | n/r |
| Bimagrumab + placebo | Obesity or overweight | n/r | 52 | n/r | n/r |